Pseudotumor cerebri is a condition where pressure builds up inside your skull for no obvious reason, mimicking the symptoms of a brain tumor even though no tumor exists. The more current medical name is idiopathic intracranial hypertension (IIH), and it affects roughly 10 out of every 100,000 people in the United States. The condition is treatable, but without proper management, it can cause permanent vision loss in 5 to 15 percent of cases.
Why Pressure Builds Up
Your brain and spinal cord are surrounded by cerebrospinal fluid (CSF), a clear liquid that cushions and protects them. Normally, your body produces this fluid at a steady rate, circulates it, and reabsorbs it into the bloodstream through veins in the skull. In pseudotumor cerebri, that balance breaks down. The fluid either gets produced too fast, doesn’t drain properly, or encounters too much resistance when trying to flow back into the veins.
One well-documented mechanism involves the large veins inside the skull. When pressure in these veins rises, the fluid needs even higher pressure to push through and get reabsorbed. This creates a feedback loop: the fluid pressure climbs, which can further compress the veins, which makes drainage even harder. The result is a sustained increase in pressure that pushes on the brain and, critically, on the optic nerves.
Who Gets It
Pseudotumor cerebri overwhelmingly affects women of childbearing age who carry excess weight. In this group, rates climb to 4 to 21 per 100,000, far higher than the general population. The prevalence in the U.S. increased by about 35 percent between 2015 and 2022, likely tracking with rising obesity rates. Men and children can develop it too, but far less commonly.
Common Symptoms
Headaches are the hallmark symptom, occurring in up to 98 percent of cases. They can appear anywhere on the head (front, behind the eyes, both sides) and tend to be daily. Many people notice they’re worse in the morning or get more intense with straining, coughing, or bending over. Nausea, vomiting, and light sensitivity often accompany the headaches, which can make them look a lot like migraines.
The second major symptom is vision changes. Brief episodes of vision going dim or black, lasting just a few seconds, are common. These “transient visual obscurations” can affect one or both eyes. Some people see sudden flashes of light. Double vision, typically side-to-side, happens when the pressure affects the nerve that controls outward eye movement. Persistent vision loss occurs in up to 32 percent of untreated cases.
Pulsatile tinnitus, a rhythmic whooshing or heartbeat sound in one or both ears, shows up in about 60 percent of people with pseudotumor cerebri. It’s caused by turbulent blood flow in the veins near the ear as they deal with increased pressure. Neck and back pain are also reported frequently.
How It’s Diagnosed
Diagnosis follows a set of criteria known as the modified Dandy criteria, which essentially work by ruling everything else out. To qualify, you need signs of elevated intracranial pressure, a normal neurological exam (no weakness, numbness, or other focal findings), normal brain imaging aside from a few specific signs of high pressure, and no other identifiable cause.
Brain imaging, usually an MRI, is done first to rule out tumors, blood clots, or blocked fluid pathways. The scan may show subtle clues like a partially empty space where the pituitary gland sits or swollen sheaths around the optic nerves, both of which point toward elevated pressure rather than a mass.
The definitive test is a lumbar puncture (spinal tap), where a needle is placed in the lower back to measure the fluid pressure directly. A reading above 250 mm of water is the diagnostic threshold for adults. Some patients with lower pressures can still have the condition if their optic nerves are particularly sensitive, but this is less common. The fluid itself is tested and should come back normal. If the composition is abnormal, doctors look for other diagnoses like infection or inflammation.
What Causes Secondary Cases
When the condition has an identifiable trigger rather than arising on its own, it’s called secondary intracranial hypertension. Several medications are known culprits: tetracycline antibiotics, vitamin A and its derivatives (including high-dose supplements and acne medications like isotretinoin), lithium, growth hormone, and corticosteroids (particularly when being tapered off after long-term use). Amiodarone, a heart rhythm drug, has also been implicated. If you develop symptoms while taking any of these, the medication is usually the first thing your doctor will address.
Treatment: Medication and Weight Loss
For most people, treatment starts with a medication that reduces how much cerebrospinal fluid the body produces. The standard first-line drug works by inhibiting an enzyme in the fluid-producing cells of the brain. Doctors typically start at a moderate dose and increase it gradually based on how your symptoms and vision respond. Side effects are common and include tingling in the fingers and toes, a metallic taste with carbonated drinks, fatigue, and sometimes kidney stones, which is why regular blood work is part of follow-up.
Weight loss is one of the most effective interventions. Losing just 6 to 10 percent of body weight often leads to remission. For someone weighing 200 pounds, that’s 12 to 20 pounds. This doesn’t have to happen overnight, but sustained weight reduction is the closest thing to a long-term fix for many patients. The mechanism isn’t entirely clear, but reducing abdominal and overall body fat appears to lower venous pressure and improve fluid dynamics inside the skull.
When Surgery Becomes Necessary
Surgery is reserved for people whose vision is deteriorating despite maximum medical treatment, or who present with rapid, severe vision loss from the start. There are two main approaches, chosen based on whether vision loss or headache is the bigger problem.
Optic nerve sheath fenestration is a procedure where small slits are made in the tissue surrounding the optic nerve, allowing trapped fluid to drain and relieving direct pressure on the nerve. It’s preferred when vision is the primary concern. In a large case series, 94 percent of eyes showed improvement in visual sharpness, and 88 percent had their visual fields stabilize or improve. The procedure targets the eye specifically and doesn’t always help headaches.
CSF shunting redirects excess fluid from either the brain’s ventricles or the spinal canal into the abdomen, where the body absorbs it. Shunts are better for controlling headaches and work well for vision too, with 80 to 89 percent of patients seeing overall symptom improvement depending on the type of shunt. The trade-off is a significant revision rate: up to 60 percent of one type of shunt and 30 percent of another eventually need surgical repair or replacement due to blockage or malfunction. Shunts are a commitment to ongoing monitoring.
Long-Term Outlook
With treatment, most people with pseudotumor cerebri can preserve their vision and manage their symptoms. The 5 to 15 percent who develop severe, permanent vision loss tend to be those diagnosed late, those who don’t respond to initial treatment, or those who struggle with sustained weight management. Regular eye exams with visual field testing are the cornerstone of monitoring, because vision loss from optic nerve damage can progress silently before you notice it yourself.
Many patients deal with persistent, disabling headaches even after the pressure is brought under control. The headaches can take on a life of their own, becoming chronic and requiring separate management. Recurrence of high pressure is also possible, particularly with weight regain, so long-term follow-up is standard even after symptoms initially resolve.